[1] (a) Aurélien B, Shuji H, Béatrice Q S, et al. Application of an amidyl radical cascade to the total synthesis of (±)-fortucine leading to the structural revision of kirkine[J]. Tetrahedron, 2009, 65(33): 6 730-6 738; (b) Tung T D, Tuan T D, Fischer C, et al. Synthesis of pyrazole-3-carboxylates and pyrazole-1,5-dicarboxylates by one-pot cyclization of hydrazone dianions with diethyl oxalate[J]. Tetrahedron, 2008, 64(9): 2 207-2 215; (c) Wang Jian-ping(王建平), Fu Yong-ju(付永举), Yin Wei-ping(尹卫平), et al. Synthesis and characterization of biological active hydrazone derivatives(具有生物活性的芳香族腙类衍生物的合成与表征)[J]. J Org Chem(有机化学), 2007, 27(4): 524-527; (d) Enders D, Voith M, Ince S J. Preparation and reactions of 2,2-dimethyl-1,3-dioxan-5-one-SAMPhydrazone: a versatile chiral dihydroxyacetone equivalent[J\. Synthesis, 2002, (12): 1 775-1 779; (e) Job A, Janeck C F, Bettray W, et al. The SAMP/RAMP-hydrazone methodology in asymmetric synthesis
[J]. Tetrahedron, 2002, 58(1): 2 253-2 329.
[2] (a) Lanthier C M, Parniak M A, Dmitrienko G I. Inhibition of carboxypeptidase a by N-(4-t-butylbenzoyl)- 2-hydroxy-1-naphthaldehyde hydrazone[J]. Bioorg Med Chem Lett, 1997, 7(12): 1 557-1 562; (b) Horiuchi T, Chiba J, Uoto K, et al. Discovery of novel thieno[2,3-d-]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1CDK4: synthesis, biological evaluation, and structure-activity relationships[J]. Bioorg Med Chem Lett, 2009, 19(2): 305-308.
[3] Mukherjee R, Jaggi M, Rajendran P, et al. Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyaxryloyl ester derivatives of betulinic acid as anti-angogenic agents[J]. Bioorg Med Chem Lett, 2004, 14(12): 3 169-3 172.
[4] (a) Zhong X, Wei H L, Liu W S, et al. The crystal structures of copper(II), manganese(II), and nickel(II) complexes of a (Z)-2-hydroxy-N′-(2-oxoindolin-3-ylidene) benzohydrazide-potential antitumor agents[J]. Bioorg Med Chem Lett, 2007, 17(13): 3 774-3 777; (b) Morgan L R, Jursic B S, Hooper C L, et al. Anticancer activity for 4,4′-dihydroxybenzophenone-2,4-dinitro-phenylhydrazone(A-007) analogues and their abilities to interact with lymphoendothelial cell surface markers[J]. Bioorg Med Chem Lett, 2002, 12(23): 3 407-3 411.
[5] Melnyk P, Leroux V, Sergheraert C, et al. Design, synthesis and in vitro antimalarial activity of an acylhydrazone library[J]. Bioorg Med Chem Lett, 2006, 16(1): 31-35.
[6] Tian B H, He M Z, Tang S X, et al. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein[J]. Bioorg Med Chem Lett, 2009, 19(8): 2 162-2 167.
[7] Chiarantini L, Cerasi A, Giorgi L, et al. Dinuclear copper(II) complex as nitric oxide scavenger in a stimulated murine macrophage model[J]. Bioconjugate Chem, 2003, 14(6): 1 165-1 170.
[8] (a) Wang P G, Xian M, Tang X P, et al. Nitric oxide donors: chemical activities and biological applications[J]. Chem Rev, 2002, 102(4): 1 091-1 134; (b) Gerald M R, Pei T, Sovity P. Mechanism of freeradical generation by nitric oxide synthase[J]. Chem Rev, 2002, 102(4): 1 191-1 200; (c) Nagano T, Yoshimura T. Bioimaging of nitric oxide[J]. Chem Rev, 2002, 102(4): 1 235-1 270; (d) McCleverty J A. Chemistry of nitric oxide relevant to biology[J]. Chem Rev, 2004, 104(2): 403- 418; (e) Masami Y, Takashi I, Masayuki I, et al. Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis andbiological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate[J]. J Med Chem, 2005, 48 (23): 7 457-7 467; (f) Liu Zong-quan(柳忠全), Shang Xiao-jie(尚筱洁), Luo Hai-qing(罗海清), et al. Progress in chemistry of nitric oxide(一氧化氮化学性质的研究进展)[J]. Chinese J Org Chem(有机化学), 2006, 26(9): 1 317-1 321.
[9] Yang D S, Zhu H Y, Guo Y N, et al. Configuration-specific reaction of nitric oxide with aldehyde arylhydrazones[J]. Chinese J Chem, 2010, 28(7): 1 193-1 198.
[10] Wu W T, Su G, Lu Z, et al. Stereoselective nitration of asymmetric hydrazones with nitric oxide[J]. Tetrahedron Lett, 2007, 48: 8 293-8 296.
[11] Yang D S, Lei L D, Liu Z Q, et al. A novel reaction of ketone arylhydrazones with nitric oxide[J]. Tetrahedron Lett, 2003, 44: 7 245-7 247.
[12] Xu Min(徐敏), Zhang Gao(张皋), Wang Min-chang(王民昌),et al. An NMR study on chiral fungicide difenoconazole(苯醚甲环唑非对映异构体的NMR研究)[J]. Chinese J Magn Reson(波谱学杂志),2010, 27(4): 642-649.
[13] Zhou Qiu-ju(周秋菊), Xiang Jun-feng(向俊锋), Tang Ya-lin(唐亚林). Application of nuclear magnetic resonance spectroscopy in drug discovery(核磁共振波谱在药物发现中的应用)[J]. Chinese J Magn Reson(波谱学杂志), 2010, 27(1): 68-79.
[14] (a) Behforouz M, Bolan J L, Flynt M S. 2,4-Dinitrophenylhydrazones: a modified method for the preparation of these derivatives and an explanation of previous conflicting results[J]. J Org Chem, 1985, 50 (8): 1 186-1 189; (b) Zhang J, Hertzler R L, Eisenbrun E J. Preparing and purifying 2,4-dinitrophenylhydrazones: alternatives to the brady procedure[J]. J Chem Edu, 1992, 69(12): 1 037-1 038.
[15] Zhao L F. (E)-1-(2,4-Dinitrophenyl)-2-(2-isopropyl-5-methyl-1-nitrocyclohexyl)diazene[J]. Acta Cryst E, 2006, 62(6): O2 160-O2 162. |